HTBA heralds new era of growth with announcement of Miura Partners as its majority shareholder
HealthTech BioActives (HTBA), a science-based global leader in the manufacture of citrus flavonoids and active forms of vitamin B12, is pleased to announce Miura Partners as its new majority shareholder,...
Read moreDetails

















